<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361190</url>
  </required_header>
  <id_info>
    <org_study_id>2014-07-0062</org_study_id>
    <nct_id>NCT02361190</nct_id>
  </id_info>
  <brief_title>Effects of Fast Acting Testosterone Nasal Spray on Anxiety</brief_title>
  <official_title>Effects of Fast Acting Testosterone Nasal Spray on Anxiety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will test the effects of a fast-acting testosterone nasal spray on the
      fear reactions of young men to two distinct anxiety challenges (social and nonsocial) using a
      double-blind randomized experimental design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim 1: Test the hypothesis that men administered testosterone nasal spray will result in
      lower levels of anxiety (anticipatory and situational) and greater levels of approach
      behavior in response to two distinct (social and nonsocial) anxiety challenges relative to
      men administered placebo spray.

      Aim 2: Test the hypothesis that anxiety challenge type (social versus nonsocial) will
      moderate the effects of testosterone administration on subjects' responses to challenge.

      Aim 3: Test the hypothesis that rejection sensitivity - heightened sensitivity to evaluative
      threat - will moderate the effects of drug condition on response to the two anxiety challenge
      tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Magnitude of behavioral approach</measure>
    <time_frame>30 minutes</time_frame>
    <description>Subjects will be asked to approach a fearful object. Approach will be measured as number of steps (out of 18) the subject completes, with each step bringing the subject closer to the target object</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Placebo nasal spray</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will inhale approximately 40ml aqueous solution via intranasal route</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Testosterone nasal spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will inhale approximately 40ml aqueous, testosterone-containing solution via intranasal route</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone</intervention_name>
    <description>Administration of 1ml aqueous nasal spray containing 7mg testosterone propionate</description>
    <arm_group_label>Testosterone nasal spray</arm_group_label>
    <other_name>Testosterone propionate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administration of 1ml aqueous saline spray</description>
    <arm_group_label>Placebo nasal spray</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male, 18 years of age or older

        Exclusion Criteria:

          -  Male breast cancer

          -  Obstructive sleep apnea

          -  Suspected or diagnosed prostate cancer

          -  Male breast cancer

          -  Obstructive sleep apnea

          -  Diabetes

          -  Heart Disease

          -  Liver disease (e.g., hepatitis)

          -  Kidney disease

          -  Thyroid disease

          -  Tuberculosis or history if positive TB test

          -  Infection or fever in the past 7 days

          -  Surgeries within the last 6 weeks

          -  Anemia

          -  Gastrointestinal disease

          -  Respiratory disease (e.g., asthma or chronic bronchitis)

          -  Other (Please list)

          -  Reynaud's Disease

          -  Type 2 diabetes

          -  Diagnosed hypersensitivity to cold

          -  Warfarin (Coumadin) for thinning blood

          -  Insulin or any oral drugs for diabetes

          -  Propranolol (Inderal)

          -  Oxyphenbutazone

          -  Imipramine

          -  Any kind of corticosteroid drug

          -  Insulin

          -  Steroids

          -  Statins (i.e.., cholesterol lowering drugs)

          -  Sleeping pills

          -  Drugs to treat hormone disorders

          -  Antibiotics in the past 7 days

          -  Gastrointestinal disease

          -  Pain Killers -
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert A Josephs, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas at Austin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas at Austin Department of Psychology</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>February 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2015</study_first_posted>
  <last_update_submitted>June 9, 2016</last_update_submitted>
  <last_update_submitted_qc>June 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

